Skip to content

Reversal of opioid-induced respiratory depression (OIRD) by ketamine in healthy volunteers

Reversal of opioid-induced respiratory depression (OIRD) by ketamine in healthy volunteers

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24921
Enrollment
12
Registered
2017-02-28
Start date
2016-10-21
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ketamine

Interventions

Ventilation will be elevated by isohypercapnic ventilation to 20L/min, if a steady-state is reached, there will be started with remifentanil. The ventilation will be decreased with 40-50%. After reach

Sponsors

LUMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Healthy male or female volunteers; - Age: 18 - 40 years; - Body mass index < 30 kg/m2; - Able to give informed consent.

Exclusion criteria

Exclusion criteria: - Known or suspected neuromuscular or a (family) history of any neuromuscular disease; - A history of allergic reaction to food or medication including study medication; - Any current or previous medical (including high blood pressure), neurological or psychiatric illness (including a history of anxiety); - Alcohol abuse (> 21 units/week); - Illicit drug use in the past 30 days before inclusion; - Pregnancy or lactation; - Participation in any medical or drug trial in the month prior to the current study.

Design outcomes

Primary

MeasureTime frame
- effect of ketamine on ventilation after OIRD.

Secondary

MeasureTime frame
- effect of ketamine on ventilation - arterial blood sampling for PK - hemodynamic effect

Contacts

Public ContactAlbert Dahan

Leiden University Medical Center (LUMC), Department of Anesthesiology, P.O. Box 9600

a.dahan@lumc.nl+31 (0)71 5262301

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)